Pituitary Acth Hypersecretion

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2026-08-05
EMA Authorised: Signifor (pasireotide) — Recordati Rare Diseases
Signifor (pasireotide) has been authorised in the EU for acromegaly and pituitary ACTH hypersecretion.